Crocs, Inc. (NASDAQ:CROX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the thirteen ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $105.3333.
Several equities research analysts recently weighed in on CROX shares. UBS Group cut their price objective on Crocs from $110.00 to $85.00 and set a "neutral" rating on the stock in a report on Monday, August 11th. Bank of America cut their price objective on Crocs from $135.00 to $99.00 and set a "buy" rating on the stock in a report on Friday, August 8th. The Goldman Sachs Group cut their target price on Crocs from $88.00 to $87.00 and set a "sell" rating on the stock in a report on Tuesday, July 22nd. KeyCorp reduced their price target on Crocs from $120.00 to $95.00 and set an "overweight" rating on the stock in a research report on Friday, August 8th. Finally, Needham & Company LLC upped their price target on Crocs from $89.00 to $100.00 and gave the company a "buy" rating in a research report on Friday, August 29th.
View Our Latest Stock Report on CROX
Crocs Trading Down 0.3%
NASDAQ CROX opened at $80.95 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.54 and a debt-to-equity ratio of 0.97. Crocs has a twelve month low of $73.76 and a twelve month high of $151.13. The company has a market cap of $4.42 billion, a price-to-earnings ratio of 21.70, a price-to-earnings-growth ratio of 1.87 and a beta of 1.40. The business's fifty day moving average is $93.64 and its 200 day moving average is $99.35.
Crocs (NASDAQ:CROX - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The textile maker reported $4.23 earnings per share for the quarter, beating the consensus estimate of $4.01 by $0.22. Crocs had a return on equity of 44.15% and a net margin of 5.72%.The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter last year, the business posted $4.01 EPS. Crocs's revenue for the quarter was up 3.4% on a year-over-year basis. Crocs has set its Q3 2025 guidance at EPS. As a group, sell-side analysts expect that Crocs will post 13.2 EPS for the current fiscal year.
Insider Transactions at Crocs
In related news, Director John B. Replogle purchased 3,261 shares of Crocs stock in a transaction on Friday, August 8th. The shares were purchased at an average price of $76.69 per share, for a total transaction of $250,086.09. Following the transaction, the director owned 15,417 shares of the company's stock, valued at approximately $1,182,329.73. This represents a 26.83% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Susan L. Healy purchased 2,000 shares of Crocs stock in a transaction on Tuesday, August 12th. The stock was bought at an average price of $76.56 per share, for a total transaction of $153,120.00. Following the transaction, the executive vice president directly owned 50,078 shares in the company, valued at approximately $3,833,971.68. The trade was a 4.16% increase in their position. The disclosure for this purchase can be found here. Insiders own 3.00% of the company's stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in CROX. Costello Asset Management INC acquired a new position in shares of Crocs in the 1st quarter valued at about $32,000. Larson Financial Group LLC lifted its stake in shares of Crocs by 541.8% in the 1st quarter. Larson Financial Group LLC now owns 353 shares of the textile maker's stock valued at $37,000 after purchasing an additional 298 shares during the period. IMA Advisory Services Inc. acquired a new position in shares of Crocs in the 1st quarter valued at about $40,000. Brooklyn Investment Group acquired a new position in shares of Crocs in the 1st quarter valued at about $40,000. Finally, Allworth Financial LP lifted its stake in shares of Crocs by 120.7% in the 2nd quarter. Allworth Financial LP now owns 448 shares of the textile maker's stock valued at $45,000 after purchasing an additional 245 shares during the period. 93.44% of the stock is owned by institutional investors and hedge funds.
Crocs Company Profile
(
Get Free Report)
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Crocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.
While Crocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.